Blog

3 April 2026

Pediatric Allergic Contact Dermatitis: Key Allergens and Screening Tips

Discover key allergens causing pediatric allergic contact dermatitis and expert screening tips to protect your child's skin health effectively.
Read more
Pediatric Allergic Contact Dermatitis: Key Allergens and Screening Tips
EVO301’s Novel IL-18 Targeting Shows Promise for Tough Atopic Dermatitis Cases

EVO301’s Novel IL-18 Targeting Shows Promise for Tough Atopic Dermatitis Cases

EVO301 targets IL-18 with a novel approach, offering hope for tough atopic dermatitis cases unresponsive to current treatments. Learn more...
4 04 2026
Read more
Envudeucitinib Shows Promising Results as Oral TYK2 Inhibitor for Psoriasis

Envudeucitinib Shows Promising Results as Oral TYK2 Inhibitor for Psoriasis

Envudeucitinib, a next-gen oral TYK2 inhibitor, shows promising phase 3 results for treating moderate to severe plaque psoriasis. Learn more...
2 04 2026
Read more
Effective Early Treatments for Managing Hidradenitis Suppurativa Pain and Scarring

Effective Early Treatments for Managing Hidradenitis Suppurativa Pain and Scarring

Discover effective early treatments for managing hidradenitis suppurativa pain and scarring to improve quality of life and skin health.
31 03 2026
Read more
Cross-Cultural Stigma and Challenges Faced by People with Vitiligo

Cross-Cultural Stigma and Challenges Faced by People with Vitiligo

Explore cross-cultural stigma and challenges faced by people with vitiligo, highlighting beliefs, discrimination, and coping across diverse communities.
28 03 2026
Read more
Sonelokimab Shows Promising Long-Term Results for Hidradenitis Suppurativa

Sonelokimab Shows Promising Long-Term Results for Hidradenitis Suppurativa

Sonelokimab shows promising long-term results in treating moderate to severe hidradenitis suppurativa, offering hope for better inflammation control.
29 03 2026
Read more
Biogen’s Litifilimab Shows Promise in Phase 2 Trial for Cutaneous Lupus

Biogen’s Litifilimab Shows Promise in Phase 2 Trial for Cutaneous Lupus

Biogen’s litifilimab shows promising Phase 2 results for cutaneous lupus, offering hope for a targeted treatment in this challenging skin...
30 03 2026
Read more
Cutting-Edge Treatments Transform Atopic Dermatitis Care in 2026

Cutting-Edge Treatments Transform Atopic Dermatitis Care in 2026

Discover how cutting-edge treatments like monoclonal antibodies and JAK inhibitors are revolutionizing atopic dermatitis care in 2026 for better relief.
26 03 2026
Read more
Managing Urticaria and Skin Conditions Safely During Pregnancy: New Study Insights

Managing Urticaria and Skin Conditions Safely During Pregnancy: New Study Insights

Discover new insights on safely managing urticaria and other skin conditions during pregnancy, focusing on treatment, symptoms, and physician guidance.
27 03 2026
Read more